Journal of Clinical Oncology, ISSN 0732-183X, 10/2015, Volume 33, Issue 30, pp. 3488 - 3515
Purpose To provide evidence-based recommendations to update the American Society of Clinical Oncology guideline on systemic therapy for stage IV non-small-cell...
PALLIATIVE CARE | GROWTH-FACTOR RECEPTOR | CHEMOTHERAPY-NAIVE PATIENTS | 1ST-LINE TREATMENT | ONCOLOGY | RANDOMIZED PHASE-III | DOUBLE-BLIND | TYROSINE KINASE INHIBITOR | QUALITY-OF-LIFE | PACLITAXEL PLUS CARBOPLATIN | TREATED JAPANESE PATIENTS | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - drug therapy | Humans | Lung Neoplasms - pathology | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Randomized Controlled Trials as Topic | ASCO Special | Gdln1 | Thor5 | Thor6
PALLIATIVE CARE | GROWTH-FACTOR RECEPTOR | CHEMOTHERAPY-NAIVE PATIENTS | 1ST-LINE TREATMENT | ONCOLOGY | RANDOMIZED PHASE-III | DOUBLE-BLIND | TYROSINE KINASE INHIBITOR | QUALITY-OF-LIFE | PACLITAXEL PLUS CARBOPLATIN | TREATED JAPANESE PATIENTS | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - drug therapy | Humans | Lung Neoplasms - pathology | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Randomized Controlled Trials as Topic | ASCO Special | Gdln1 | Thor5 | Thor6
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2009, Volume 27, Issue 36, pp. 6251 - 6266
The purpose of this article is to provide updated recommendations for the treatment of patients with stage IV non-small-cell lung cancer. A literature search...
PHASE-III TRIAL | LEUKEMIA GROUP-B | RANDOMIZED CONTROLLED-TRIALS | CISPLATIN PLUS GEMCITABINE | GROWTH-FACTOR-RECEPTOR | ONCOLOGY | MESSENGER-RNA EXPRESSION | PLATINUM-BASED CHEMOTHERAPY | QUALITY-OF-LIFE | INDIVIDUAL PATIENT DATA | GENE COPY NUMBER | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - drug therapy | Lung Neoplasms - pathology | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Humans | Index Medicus | Thor12 | Gdln1 | Asco Special | Thor5
PHASE-III TRIAL | LEUKEMIA GROUP-B | RANDOMIZED CONTROLLED-TRIALS | CISPLATIN PLUS GEMCITABINE | GROWTH-FACTOR-RECEPTOR | ONCOLOGY | MESSENGER-RNA EXPRESSION | PLATINUM-BASED CHEMOTHERAPY | QUALITY-OF-LIFE | INDIVIDUAL PATIENT DATA | GENE COPY NUMBER | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - drug therapy | Lung Neoplasms - pathology | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Humans | Index Medicus | Thor12 | Gdln1 | Asco Special | Thor5
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2011, Volume 29, Issue 28, pp. 3825 - 3831
Purpose An American Society of Clinical Oncology (ASCO) focused update updates a single recommendation (or subset of recommendations) in advance of a regularly...
PHASE-III TRIAL | PLACEBO | GEFITINIB | THERAPY | ONCOLOGY | DOCETAXEL | GEMCITABINE | ERLOTINIB | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - drug therapy | Clinical Trials, Phase III as Topic | Humans | Lung Neoplasms - pathology | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Randomized Controlled Trials as Topic | ASCO Special | Gdln1 | Thor5 | To20
PHASE-III TRIAL | PLACEBO | GEFITINIB | THERAPY | ONCOLOGY | DOCETAXEL | GEMCITABINE | ERLOTINIB | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - drug therapy | Clinical Trials, Phase III as Topic | Humans | Lung Neoplasms - pathology | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Randomized Controlled Trials as Topic | ASCO Special | Gdln1 | Thor5 | To20
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2017, Volume 35, Issue 30, pp. 3484 - 3515
Purpose Provide evidence-based recommendations updating the 2015 ASCO guideline on systemic therapy for patients with stage IV non-small-cell lung cancer...
MULTICENTER | PEMBROLIZUMAB | ONCOLOGY | RANDOMIZED PHASE-II | OPEN-LABEL | ATEZOLIZUMAB | SINGLE-ARM | 1ST-LINE THERAPY | PATIENTS PTS | NIVOLUMAB | DOCETAXEL | Lung Neoplasms - drug therapy | American Medical Association | Randomized Controlled Trials as Topic - methods | United States | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - pathology | Humans | Gene Expression Regulation, Neoplastic | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Societies, Medical | Molecular Targeted Therapy - methods | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Evidence-Based Medicine - methods | Medical Oncology - methods | Antibodies, Monoclonal, Humanized - therapeutic use | Carcinoma, Non-Small-Cell Lung - genetics | B7-H1 Antigen - genetics | Carcinoma, Squamous Cell - drug therapy | Nivolumab | Biomarkers, Tumor - genetics | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Practice Guidelines as Topic
MULTICENTER | PEMBROLIZUMAB | ONCOLOGY | RANDOMIZED PHASE-II | OPEN-LABEL | ATEZOLIZUMAB | SINGLE-ARM | 1ST-LINE THERAPY | PATIENTS PTS | NIVOLUMAB | DOCETAXEL | Lung Neoplasms - drug therapy | American Medical Association | Randomized Controlled Trials as Topic - methods | United States | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - pathology | Humans | Gene Expression Regulation, Neoplastic | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Societies, Medical | Molecular Targeted Therapy - methods | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Evidence-Based Medicine - methods | Medical Oncology - methods | Antibodies, Monoclonal, Humanized - therapeutic use | Carcinoma, Non-Small-Cell Lung - genetics | B7-H1 Antigen - genetics | Carcinoma, Squamous Cell - drug therapy | Nivolumab | Biomarkers, Tumor - genetics | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Practice Guidelines as Topic
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2004, Volume 22, Issue 2, pp. 330 - 353
LEUKEMIA GROUP-B | CISPLATIN-BASED CHEMOTHERAPY | POSITRON-EMISSION-TOMOGRAPHY | ACCELERATED RADIOTHERAPY CHART | COLONY-STIMULATING FACTORS | FINE-NEEDLE-ASPIRATION | ONCOLOGY | RANDOMIZED PHASE-III | FDG-PET SCAN | PACLITAXEL PLUS CARBOPLATIN | COMPARING PERIOPERATIVE CHEMOTHERAPY | Carcinoma, Non-Small-Cell Lung - radiotherapy | Lung Neoplasms - drug therapy | Medical Oncology | Carcinoma, Non-Small-Cell Lung - surgery | Prognosis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Humans | Lung Neoplasms - radiotherapy | Lung Neoplasms - surgery | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Practice Guidelines as Topic
Journal Article
Psycho‐Oncology, ISSN 1057-9249, 12/2010, Volume 19, Issue 12, pp. 1285 - 1293
Objective: This study investigated depressive symptomatology in lung cancer patients and their identified caregiver. Methods: We conducted semi‐structured...
lung cancer | caregivers | depression | communication | oncology | SOCIAL SCIENCES, BIOMEDICAL | ADJUSTMENT | PSYCHOLOGY | PARTNERS | BREAST-CANCER | COUPLES | PSYCHOLOGY, MULTIDISCIPLINARY | MORBIDITY | ASSESSMENT-TOOL | PSYCHOLOGICAL DISTRESS | QUALITY-OF-LIFE | ATTRIBUTIONS | Cross-Sectional Studies | Caregivers - psychology | Humans | Middle Aged | Family Health | Male | Socioeconomic Factors | Depression - etiology | Spouses - psychology | Aged, 80 and over | Depression - psychology | Adult | Female | Interviews as Topic | Aged | Lung Neoplasms - nursing | Terminal Care | Lung Neoplasms - psychology | Communication | Caregivers | Psychological aspects | Lung cancer | Families & family life | Oncology | Mental depression | Multivariate analysis
lung cancer | caregivers | depression | communication | oncology | SOCIAL SCIENCES, BIOMEDICAL | ADJUSTMENT | PSYCHOLOGY | PARTNERS | BREAST-CANCER | COUPLES | PSYCHOLOGY, MULTIDISCIPLINARY | MORBIDITY | ASSESSMENT-TOOL | PSYCHOLOGICAL DISTRESS | QUALITY-OF-LIFE | ATTRIBUTIONS | Cross-Sectional Studies | Caregivers - psychology | Humans | Middle Aged | Family Health | Male | Socioeconomic Factors | Depression - etiology | Spouses - psychology | Aged, 80 and over | Depression - psychology | Adult | Female | Interviews as Topic | Aged | Lung Neoplasms - nursing | Terminal Care | Lung Neoplasms - psychology | Communication | Caregivers | Psychological aspects | Lung cancer | Families & family life | Oncology | Mental depression | Multivariate analysis
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 05/2017, Volume 12, Issue 5, pp. 843 - 849
The aim of this study was to evaluate efficacy of maintenance sunitinib after first-line chemotherapy for stage IIIB/IV NSCLC. Cancer and Leukemia Group B...
Sunitinib | Maintenance | NSCLC | Tyrosine kinase inhibitor | MULTICENTER | THERAPY | ONCOLOGY | RESPIRATORY SYSTEM | Lung Neoplasms - drug therapy | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Fatigue - chemically induced | Indoles - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Pyrroles - administration & dosage | Hypertension - chemically induced | Aged, 80 and over | Pyrroles - adverse effects | Adult | Female | Maintenance Chemotherapy | Neutropenia - chemically induced | Drug Eruptions - etiology | Bevacizumab - administration & dosage | Double-Blind Method | Anemia - chemically induced | Survival Rate | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Disease-Free Survival | Indoles - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Quality of Life | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Platinum Compounds - administration & dosage | Neoplasm Staging
Sunitinib | Maintenance | NSCLC | Tyrosine kinase inhibitor | MULTICENTER | THERAPY | ONCOLOGY | RESPIRATORY SYSTEM | Lung Neoplasms - drug therapy | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Fatigue - chemically induced | Indoles - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Pyrroles - administration & dosage | Hypertension - chemically induced | Aged, 80 and over | Pyrroles - adverse effects | Adult | Female | Maintenance Chemotherapy | Neutropenia - chemically induced | Drug Eruptions - etiology | Bevacizumab - administration & dosage | Double-Blind Method | Anemia - chemically induced | Survival Rate | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Disease-Free Survival | Indoles - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Quality of Life | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Platinum Compounds - administration & dosage | Neoplasm Staging
Journal Article
International Journal of Gynecological Pathology, ISSN 0277-1691, 03/2015, Volume 34, Issue 2, pp. 136 - 142
Nuclear protein of the testis (NUT) midline carcinoma (NMC) is an uncommon, relatively recently characterized carcinoma, which is defined by NUT gene...
NUT | Ovary | Midline carcinoma | DIAGNOSIS | TUMOR | THYMOMA | PATHOLOGY | FEATURES | OBSTETRICS & GYNECOLOGY | Oncogene Proteins - genetics | Ovarian Neoplasms - secondary | Mediastinal Neoplasms - pathology | Humans | Adult | Female | Nuclear Proteins - genetics | Carcinoma - secondary
NUT | Ovary | Midline carcinoma | DIAGNOSIS | TUMOR | THYMOMA | PATHOLOGY | FEATURES | OBSTETRICS & GYNECOLOGY | Oncogene Proteins - genetics | Ovarian Neoplasms - secondary | Mediastinal Neoplasms - pathology | Humans | Adult | Female | Nuclear Proteins - genetics | Carcinoma - secondary
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. 8040 - 8040
Journal Article
Journal of Oncology Practice, ISSN 1554-7477, 12/2017, Volume 13, Issue 12, pp. 780 - 783
Journal Article
Zhongguo fei ai za zhi = Chinese journal of lung cancer, ISSN 1009-3419, 03/2010, Volume 13, Issue 3, pp. 171 - 189
Journal Article
Zhongguo Fei Ai Za Zhi, ISSN 1009-3419, 03/2010, Volume 13, Issue 3
Journal Article
Acta Neurochirurgica, ISSN 0001-6268, 1/2010, Volume 152, Issue 1, pp. 163 - 168
The authors present a case of a 56-year-old man with altered mental status. Magnetic resonance imaging (MRI) of the brain revealed non-enhancing abnormalities...
Primary CNS lymphoma | Brain tumor | Neurology | T-cell lymphoblastic lymphoma | Chemotherapy | Surgical Orthopedics | Altered mental status | Medicine & Public Health | Minimally Invasive Surgery | Interventional Radiology | Neurosurgery | Neuroradiology | SURGERY | ORIGIN | METHOTREXATE | PRIMARY-CNS-LYMPHOMA | CENTRAL-NERVOUS-SYSTEM | RADIOTHERAPY | CLINICAL NEUROLOGY | Immunohistochemistry | Injections, Spinal | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Injections, Intravenous | Brain Neoplasms - psychology | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - psychology | Brain Neoplasms - diagnosis | Humans | Middle Aged | Male | Brain Neoplasms - drug therapy | Antimetabolites, Antineoplastic - administration & dosage | Magnetic Resonance Imaging | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | Biopsy | Methotrexate - administration & dosage | Mental Disorders - etiology | Diagnosis | Non-Hodgkin's lymphomas | Methotrexate | T cells | Brain tumors | Case Report
Primary CNS lymphoma | Brain tumor | Neurology | T-cell lymphoblastic lymphoma | Chemotherapy | Surgical Orthopedics | Altered mental status | Medicine & Public Health | Minimally Invasive Surgery | Interventional Radiology | Neurosurgery | Neuroradiology | SURGERY | ORIGIN | METHOTREXATE | PRIMARY-CNS-LYMPHOMA | CENTRAL-NERVOUS-SYSTEM | RADIOTHERAPY | CLINICAL NEUROLOGY | Immunohistochemistry | Injections, Spinal | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Injections, Intravenous | Brain Neoplasms - psychology | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - psychology | Brain Neoplasms - diagnosis | Humans | Middle Aged | Male | Brain Neoplasms - drug therapy | Antimetabolites, Antineoplastic - administration & dosage | Magnetic Resonance Imaging | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | Biopsy | Methotrexate - administration & dosage | Mental Disorders - etiology | Diagnosis | Non-Hodgkin's lymphomas | Methotrexate | T cells | Brain tumors | Case Report
Journal Article
Journal of Pediatric Gastroenterology and Nutrition, ISSN 0277-2116, 07/2002, Volume 35, Issue 1, pp. 5 - 6
Journal Article
Journal of Pediatric Gastroenterology and Nutrition, ISSN 0277-2116, 08/2002, Volume 35, Issue 2, pp. 111 - 112
Journal Article
Journal of Pediatric Gastroenterology and Nutrition, ISSN 0277-2116, 09/2002, Volume 35, Issue 3, pp. 242 - 243
Journal Article